. 2017 Aug 14;145(2):219–236. doi: 10.1017/S0031182017000993
© Cambridge University Press 2017
This is an Open Access article, distributed under the terms of the CreativeCommons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 8.
Antiviral drugs that could be repurposed as antileishmanials.